Asia Pacific News Network
SEE OTHER BRANDS

Following the news from Asia and the Pacific

Asia Pacific News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Network.

Press releases published on July 23, 2025

4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock

4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock

The trial will evaluate safety, dosing, and efficacy in patients with cardiogenic shock Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial …

Das 2025 Belt and Road Journalists Forum stellt „Förderung des Dialogs zwischen den Zivilisationen und der globalen Modernisierung durch die Kraft der Presse“ in den Mittelpunkt

Das 2025 Belt and Road Journalists Forum stellt „Förderung des Dialogs zwischen den Zivilisationen und der globalen Modernisierung durch die Kraft der Presse“ in den Mittelpunkt

GANZHOU, China, July 23, 2025 (GLOBE NEWSWIRE) -- Das 2025 Belt and Road Journalists Forum (Forum der „Neuen Seidenstraße“) fand am 19. Juli in Ganzhou in der Provinz Jiangxi statt. Fast einhundert Leiterinnen und Leiter journalistischer Organisationen …

Le Forum 2025 des journalistes de l’initiative « Belt and Road » entend « Promouvoir le dialogue des civilisations et la modernisation à l’échelle mondiale grâce au pouvoir des journalistes »

Le Forum 2025 des journalistes de l’initiative « Belt and Road » entend « Promouvoir le dialogue des civilisations et la modernisation à l’échelle mondiale grâce au pouvoir des journalistes »

GANZHOU, Chine, 23 juill. 2025 (GLOBE NEWSWIRE) -- Le Forum 2025 des journalistes de l’initiative « Belt and Road » (Une ceinture, une route) s’est tenu le 19 juillet à Ganzhou, dans la province du Jiangxi. Près d’une centaine de responsables d’ …

PONY AI Inc. Starts Gen-7 Robotaxi Road Testing In Beijing, Completing Major City Testing Rollout

PONY AI Inc. Starts Gen-7 Robotaxi Road Testing In Beijing, Completing Major City Testing Rollout

BEIJING, China, July 23, 2025 (GLOBE NEWSWIRE) -- PONY AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in large-scale autonomous mobility, today announced that the seventh-generation (“Gen-7”) Beijing Automotive Industry Corporation (“ …

Aurora Mobile Explores Strategic Opportunities in Real World Asset (RWA) Market

Aurora Mobile Explores Strategic Opportunities in Real World Asset (RWA) Market

SHENZHEN, China, July 23, 2025 (GLOBE NEWSWIRE) -- Recent reports have indicated that Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, has been …

Fire Truck Market Projected to Reach $9.6 billion by 2030, Globally, at a CAGR Of 2.7%, Says MarketsandMarkets™

Fire Truck Market Projected to Reach $9.6 billion by 2030, Globally, at a CAGR Of 2.7%, Says MarketsandMarkets™

Delray Beach, FL, July 23, 2025 (GLOBE NEWSWIRE) -- Fire Truck Market is estimated to grow from USD 8.1 billion in 2024 to USD 9.6 billion by 2030, at a CAGR of 2.7%, as per the recent study by MarketsandMarkets™.  Rapid urbanization, infrastructural …

Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening

Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening

VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …

Tensor Processing Unit (TPU) Market Set to Hit USD 24.1 Billion by 2032, Growing at 31.90% CAGR, Fueled by Rapid AI and Machine Learning Adoption | AnalystView Market Insights

Tensor Processing Unit (TPU) Market Set to Hit USD 24.1 Billion by 2032, Growing at 31.90% CAGR, Fueled by Rapid AI and Machine Learning Adoption | AnalystView Market Insights

San Francisco, USA, July 23, 2025 (GLOBE NEWSWIRE) -- The global Tensor Processing Unit (TPU) Market is poised for substantial growth, with projections indicating a compound annual growth rate (CAGR) of 31.90%, reaching a market value of approximately USD …

Cytovation to Advance Development of CY-101 for Cancers Driven by Dysfunction of Wnt/β-catenin Signalling Under International Nonproprietary Name of Getacatetide

Cytovation to Advance Development of CY-101 for Cancers Driven by Dysfunction of Wnt/β-catenin Signalling Under International Nonproprietary Name of Getacatetide

Plans to initiate Phase 2 clinical trial in Adrenocortical Carcinoma in early 2026 through unique partnership between Cytovation, Cancer Research UK and the Norwegian Cancer Society Bergen, Norway, July 23, 2025 – Cytovation ASA, a clinical stage oncology …

50-Day Countdown to the 2025 CIFTIS Starts

50-Day Countdown to the 2025 CIFTIS Starts

BEIJING, July 23, 2025 (GLOBE NEWSWIRE) -- The 2025 China International Fair for Trade in Services (CIFTIS) will be held from September 10 to 14 at Shougang Park in Beijing, with a 50-day countdown starting today. As a key global platform for exchange and …

Arclaim: Unlocking New Possibilities in DeFi Staking with Smart Contracts

Arclaim: Unlocking New Possibilities in DeFi Staking with Smart Contracts

WELLINGTON, New Zealand, July 22, 2025 (GLOBE NEWSWIRE) -- In the ever-changing world of decentralized finance (DeFi), staking has emerged as a cornerstone for crypto enthusiasts seeking passive income. Yet, the untapped liquidity of staked assets remains …

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions